| 注册
首页|期刊导航|临床肝胆病杂志|与直接抗病毒药物应用相关的HCV/HBV双重感染的特点及其诊治管理

与直接抗病毒药物应用相关的HCV/HBV双重感染的特点及其诊治管理

于乐成 范晔 李平

临床肝胆病杂志2018,Vol.34Issue(2):238-241,4.
临床肝胆病杂志2018,Vol.34Issue(2):238-241,4.DOI:10.3969/j.issn.1001-5256.2018.02.004

与直接抗病毒药物应用相关的HCV/HBV双重感染的特点及其诊治管理

Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents

于乐成 1范晔 1李平1

作者信息

  • 1. 南京中医药大学附属八一医院全军肝病中心,南京210002
  • 折叠

摘要

Abstract

Dual infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) has significantly different clinical,immunological,and virological features from single infection with HCV or HBV,which brings various challenges to clinical diagnosis/treatment and management.Direct-acting antiviral agents used for effective control of HCV infection may cause HBV activation,onset of hepatitis B,and even liver failure.Therefore,during the antiviral treatment of HCV infection,it is of great importance to select appropriate anti-HBV therapy and follow-up management strategies based on the status of HCV/HBV dual infection.

关键词

肝炎病毒属/肝炎病毒,乙型/重叠感染/诊断/治疗

Key words

hepacivirus/hepatitis B virus/superinfection/diagnosis/therapy

分类

医药卫生

引用本文复制引用

于乐成,范晔,李平..与直接抗病毒药物应用相关的HCV/HBV双重感染的特点及其诊治管理[J].临床肝胆病杂志,2018,34(2):238-241,4.

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文